Skip to content
P.O. Box 44 | 3856 Avonia Rd. Fairview, PA 16415-9800
Ph: (814) 304-6134
info@directallergy.com
Home
Who We Are
Who We Are
Management Team and Board of Advisors
Resources
Careers
Physicians
Physicians
Overview
Maximizing Value for the Practice
Our Process
Treating Algorithm for Allergic Rhinitis
Patient Assessment – Symptom Checker
Progress Monitoring
Physician Orientation Program
Nurse Orientation Program
Physician FAQs
Allergy Statistics
Testing and Treatment Safety
Practice
Practice
Overview
Maximizing Value for the Practice
Practice Benefits
Your Patients
Your Patients
Benefits for Your Patients
Patient Questions
Contact Us
Home
Who We Are
Who We Are
Management Team and Board of Advisors
Resources
Careers
Physicians
Physicians
Overview
Maximizing Value for the Practice
Our Process
Treating Algorithm for Allergic Rhinitis
Patient Assessment – Symptom Checker
Progress Monitoring
Physician Orientation Program
Nurse Orientation Program
Physician FAQs
Allergy Statistics
Testing and Treatment Safety
Practice
Practice
Overview
Maximizing Value for the Practice
Practice Benefits
Your Patients
Your Patients
Benefits for Your Patients
Patient Questions
Contact Us
SNOT-22 Assessment
We propose a statistically validated definition for stratification of the SNOT-22, with Mild being defined on the SNOT-22 score as 8-20, Moderate as >20-50 and Severe as >50.
SNOT 22
SNOT22WithoutFrontPage
Previous | Treating Algorithm for Allergic Rhinitis
Next | Progress Monitoring
